Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study

D. Schadendorf, A. Hauschild, S. Fosko, D. Zloty, B. Labeille, J. J. Grob, S. Puig, M. Makrutzki, F. Gilberg, A. Hong, B. Dréno, G. Rogers, R. Kunstfeld

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalJournal of the European Academy of Dermatology and Venereology
DOIs
StateAccepted/In press - 2020

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Schadendorf, D., Hauschild, A., Fosko, S., Zloty, D., Labeille, B., Grob, J. J., Puig, S., Makrutzki, M., Gilberg, F., Hong, A., Dréno, B., Rogers, G., & Kunstfeld, R. (Accepted/In press). Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.16446